GLG1 and sarcoma: Interestingly, the tested series of PDX models included five samples from so-called ‘Ewing-like’ sarcomas (3 CIC-DUX4-positive sarcomas and 2 BCOR-rearranged sarcomas), which did not exhibit any BCL11B and GLG1 immunoreactivity.